{"created":"2023-06-19T10:41:45.703749+00:00","id":1528,"links":{},"metadata":{"_buckets":{"deposit":"a67b567f-8b10-4349-961f-7120e0667f68"},"_deposit":{"created_by":3,"id":"1528","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"1528"},"status":"published"},"_oai":{"id":"oai:shiga-med.repo.nii.ac.jp:00001528","sets":["10:11:348"]},"author_link":["2836"],"item_2_alternative_title_18":{"attribute_name":"その他の言語のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"選択的PKCβ阻害剤LY333531は後根神経節細胞cGMP含量を改善することにより糖尿病性痛覚過敏を軽減する"},{"subitem_alternative_title":"センタクテキ PKCβ ソガイザイ LY333531 ハ ゴコン シンケイセツ サイボウ cGMP ガンリョウ ヲ カイゼンスル コト ニ ヨリ トウニョウビョウセイ ツウカク カビン ヲ ケイゲンスル"}]},"item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2003-09-10","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{}]}]},"item_2_description_42":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"Others","subitem_description_type":"Other"}]},"item_2_description_5":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"学位授与機関：　滋賀医科大学　博士（医学）第453号　平成15年9月10日","subitem_description_type":"Other"},{"subitem_description":"Diabetes. 52(8), p.2102-2109.","subitem_description_type":"Other"}]},"item_2_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"滋賀医科大学"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"金, 一暁"}],"nameIdentifiers":[{},{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-02-16"}],"displaytype":"detail","filename":"h453.pdf","filesize":[{"value":"4.4 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"h453.pdf","url":"https://shiga-med.repo.nii.ac.jp/record/1528/files/h453.pdf"},"version_id":"fc74f338-6577-4437-8aef-80e43448ab4c"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"other","resourceuri":"http://purl.org/coar/resource_type/c_1843"}]},"item_title":"Protein kinase Cβ selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Protein kinase Cβ selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons."}]},"item_type_id":"2","owner":"3","path":["348"],"pubdate":{"attribute_name":"公開日","attribute_value":"2014-11-13"},"publish_date":"2014-11-13","publish_status":"0","recid":"1528","relation_version_is_last":true,"title":["Protein kinase Cβ selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons."],"weko_creator_id":"3","weko_shared_id":3},"updated":"2023-06-19T11:36:16.701546+00:00"}